• 原料直供
• 试剂商城
• 直接询价

分类

• {SNA} Adenosines/P2 Nucleotide Receptor - Antagonists, Adenosines/P2 Nucleotide Receptors (Purinergics), Antagonists, Anticoagulants, Approved Therapeutics/Drug Candidates, Bioactive Small Molecule Alphabetical Index, Blood, Bristol-Myers Squibb, CI-CZ, Diversification Ready Pharma-Developed Compounds, GPCR Modulators, GPCR Proteins, Modulators and Antibodies, Immune Cell Signaling and Blood, Membrane Protein Biology Tools, Neuroscience, Neurotransmission, Neurotransmitters, Sanofi Aventis, 生化试剂, 生物活性小分子, 细胞信号转导和神经科学, 细胞生物学, 蛋白质及衍生物
• {SNA} Analytical Standards,
• Adenosines/P2 Nucleotide Receptor - Antagonists,

相关文献及参考

• [2]. Roald, H.E., et al., Clopidogrel--a platelet inhibitor which inhibits thrombogenesis in non-anticoagulated human blood independently of the blood flow conditions. Thromb Haemost, 1994. 71(5): p. 655-62.
• [3]. Ramadan, R., et al., Effects of Clopidogrel Therapy on Oxidative Stress, Inflammation, Vascular Function and Progenitor Cells in Stable Coronary Artery Disease. J Cardiovasc Pharmacol, 2013.
• Bhatt, D. L., et al., Clopidogrel with or without omeprazole in coronary artery disease. New Engl. J. Med. 363 , 1909-1917, (2010)
• Cornelissen, I., et al., Roles and interactions among protease-activated receptors and P2ry12 in hemostasis and thrombosis. Proc. Natl. Acad. Sci. U. S. A. 107 , 18605-18610, (2010) 摘要
• [1]. Geiger, J., et al., Speci
• [1]. Geiger, J., et al., Specific impairment of human platelet P2Y(AC) ADP receptor-mediated signaling by the antiplatelet drug clopidogrel. Arterioscler Thromb Vasc Biol, 1999. 19(8): p. 2007-11.

安全信息